JP2002531498A5 - - Google Patents

Download PDF

Info

Publication number
JP2002531498A5
JP2002531498A5 JP2000586327A JP2000586327A JP2002531498A5 JP 2002531498 A5 JP2002531498 A5 JP 2002531498A5 JP 2000586327 A JP2000586327 A JP 2000586327A JP 2000586327 A JP2000586327 A JP 2000586327A JP 2002531498 A5 JP2002531498 A5 JP 2002531498A5
Authority
JP
Japan
Prior art keywords
oxime
methylisatin
dichloroisatin
pharmaceutically acceptable
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000586327A
Other languages
English (en)
Other versions
JP2002531498A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1999/000679 external-priority patent/WO2000033834A1/en
Publication of JP2002531498A publication Critical patent/JP2002531498A/ja
Publication of JP2002531498A5 publication Critical patent/JP2002531498A5/ja
Pending legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項1】
一般式(I)
【化1】
Figure 2002531498
{式中、
1 は水素、C1-6 アルキル基、又は式−CH2 CO2 R’(式中、R’は水素を示す。)で表わされる基を示し、
2 は水素又はC1-6 アルキル基を示し、
3 及びR4 は相互に独立して水素又はC1-3 アルキル基を示し、そして
5 及びR6 は水素を示す。}
で表わされるイサチン誘導体又はその薬学的に容認された塩又はそのオキシド又はその水和物(但し、このイサチン誘導体は6,7−ジクロロイサチン3−オキシムでない)。
【請求項2】
O−メチル−6,7−ジクロロイサチン3−オキシム、
O−メチル−6,7−ジクロロ−1−メチルイサチン3−オキシム、
6,7−ジクロロ−1−メチルイサチン3−オキシム、
O−t−ブチル6,7−ジクロロイサチン3−オキシム、
6,7−ジフルオロイサチン3−オキシム、
6,7−ジメチルイサチン3−オキシム、
O−(カルボキシメチル)6,7−ジクロロイサチン3−オキシム、
6−クロロ−7−メチルイサチン3−オキシム又は
6−フルオロ−7−メチルイサチン3−オキシム
あるいはその薬学的に容認された塩又はそのオキシド又はその水和物である、請求項1記載の化合物。
【請求項3】
請求項1又は2記載のイサチン誘導体又はその薬学的に容認された付加塩の治療上有効な量を、少なくとも1種の薬学的に容認されたキャリヤー又は希釈剤と共に含有する、喘息、嚢胞性線維症、慢性閉塞性肺疾患及び鼻漏から選ばれた呼吸器疾患、膀胱痙攣、尿失禁又は膀胱流出閉塞の治療又は緩和するための薬学的調合物。
JP2000586327A 1998-12-04 1999-12-03 イオンチャネル活性剤としてのイサチン誘導体の使用方法 Pending JP2002531498A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199801608 1998-12-04
DK199801608 1998-12-04
PCT/DK1999/000679 WO2000033834A1 (en) 1998-12-04 1999-12-03 Use of isatin derivatives as ion channel activating agents

Publications (2)

Publication Number Publication Date
JP2002531498A JP2002531498A (ja) 2002-09-24
JP2002531498A5 true JP2002531498A5 (ja) 2007-01-25

Family

ID=8106503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000586327A Pending JP2002531498A (ja) 1998-12-04 1999-12-03 イオンチャネル活性剤としてのイサチン誘導体の使用方法

Country Status (7)

Country Link
US (2) US20020016354A1 (ja)
EP (1) EP1135123B1 (ja)
JP (1) JP2002531498A (ja)
AT (1) ATE285769T1 (ja)
AU (1) AU1648600A (ja)
DE (1) DE69922997T2 (ja)
WO (1) WO2000033834A1 (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1298704C (zh) 2000-01-24 2007-02-07 神经研究公司 具有神经营养活性的靛红衍生物
AU2001265840A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel agonists for reducing fat food comsumption
CA2433041A1 (en) * 2000-12-28 2002-07-11 Switch Biotech Aktiengesellschaft Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty
EP1361874A1 (en) * 2001-02-15 2003-11-19 Neurosearch A/S Treatment of diseases characterized by excessive or insufficient cell death
AR033095A1 (es) 2001-04-04 2003-12-03 Wyeth Corp Metodos para el tratamiento de motilidad gastrica hiperactiva
US7148007B2 (en) * 2001-07-24 2006-12-12 Kabushiki Kaisha Toshiba Method for evaluating immunotoxicity of test substance
DE10250870A1 (de) * 2002-10-31 2004-05-13 Switch Biotech Ag Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung
FR2849773B1 (fr) * 2003-01-15 2006-07-14 Oreal Composition capillaire contenant un 2-alkylidene aminooxy-acetamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute
WO2004069213A2 (en) * 2003-01-15 2004-08-19 L'oreal Cosmetic composition comprising a 2-alkylideneaminooxyacetamide
ES2365847T3 (es) 2003-10-03 2011-10-11 Veijlen N.V. Uso de derivados del ácido indolacético que aumentan la concentración sérica de igf-1 para la preparación de una composición terapéutica para el tratamiento de diversas enfermedades.
DK1667678T3 (da) 2003-10-03 2009-08-24 Veijlen N V Dyrefodersammensætning
US8846764B2 (en) * 2006-09-13 2014-09-30 The Medical College Of Wisconsin, Inc. Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases
US8232310B2 (en) * 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
JP5305704B2 (ja) * 2008-03-24 2013-10-02 富士フイルム株式会社 新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
US20120190009A1 (en) * 2010-12-14 2012-07-26 Fatah Kashanchi Viral Modulators and Processes Thereof
CN103380129B (zh) 2010-12-20 2016-04-20 阿克图拉姆生命科学股份公司 2-甲酰胺-4-哌嗪基-苯并呋喃衍生物
WO2013155341A1 (en) 2012-04-12 2013-10-17 Georgetown University Methods and compositions for treating ewings sarcoma family of tumors
AU2014340398A1 (en) 2013-10-24 2016-06-09 Georgetown University Methods and compositions for treating cancer
BR112016024034A2 (pt) * 2014-04-14 2017-12-26 Flex Pharma Inc ativadores de canal iônico e métodos de uso
WO2015160842A1 (en) * 2014-04-14 2015-10-22 Flex Pharma, Inc. Methods and formulatiions of capsaicinoids and capsinoids
CN104130175A (zh) * 2014-06-13 2014-11-05 天津科技大学 不同位置取代吲哚酮类衍生物及其应用
CA2961781C (en) 2014-10-09 2023-10-03 Oncternal Therapeutics, Inc. Indolinone compounds and uses thereof
ES2823190T3 (es) 2016-03-31 2021-05-06 Oncternal Therapeutics Inc Análogos de indolina y usos de los mismos
CN114569606B (zh) 2016-07-29 2024-04-19 英克特诺治疗公司 吲哚啉酮化合物的用途
WO2018129336A1 (en) 2017-01-06 2018-07-12 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof
WO2018136943A1 (en) 2017-01-23 2018-07-26 Flex Pharma, Inc. Compositions and methods affecting exercise performance
CN108017570A (zh) * 2017-12-21 2018-05-11 常州大学 一种靛红的生产方法
CN108721297A (zh) * 2018-05-15 2018-11-02 泰山医学院 一种减轻免疫抑制的抗肿瘤药物及其应用
CN108403690A (zh) * 2018-05-15 2018-08-17 泰山医学院 一种抑制黑色素瘤细胞增殖的药物及其应用
CN113564623A (zh) * 2021-06-17 2021-10-29 福建师范大学 电化学氧化n-取代吲哚衍生物制备靛红化合物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR65270B (en) * 1978-10-10 1980-07-31 Fujisawa Pharmaceutical Co Isatin derivatives and processes for the preparation thereof
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives
US4780477A (en) * 1985-06-08 1988-10-25 Kissei Pharmaceutical Co., Ltd. Isatin compositions having anti-ulcer activities
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use
US5192792A (en) 1990-12-07 1993-03-09 Warner-Lambert Company Isatine derivatives, and their method of use
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5514690A (en) * 1992-11-17 1996-05-07 E. R. Squibb & Sons, Inc. Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
JP3419539B2 (ja) * 1993-02-17 2003-06-23 中外製薬株式会社 インドリン−2−オン誘導体
US5565483A (en) 1995-06-07 1996-10-15 Bristol-Myers Squibb Company 3-substituted oxindole derivatives as potassium channel modulators
EP1002535A1 (en) * 1998-10-28 2000-05-24 Hrissanthi Ikonomidou New use of glutamate antagonists for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2002531498A5 (ja)
JP2003531118A5 (ja)
JP2004501916A5 (ja)
JP2008518890A5 (ja)
JP2005533860A5 (ja)
JP2002519434A5 (ja)
JP2008520662A5 (ja)
JP2007518738A5 (ja)
JP2008543860A5 (ja)
JP2002516273A5 (ja)
JP2008546770A5 (ja)
JP2002543183A5 (ja)
JP2006514626A5 (ja)
JP2005515978A5 (ja)
JP2006509749A5 (ja)
JP2007514005A5 (ja)
BG107474A (en) Carbamates derived from arylalkylamines
JP2003528918A5 (ja)
AU7145996A (en) Substituted heteroaromatic derivatives
JP2002508361A5 (ja)
JP2002506856A5 (ja)
JP2002508347A5 (ja)
JP2004526788A5 (ja)
JP2001520998A5 (ja)
JP2005525323A5 (ja)